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Abstract: The purposes of this study were to investigate the trajectory groups of depressive symptoms
and anxiety in women during pregnancy and to identify the factors associated with those groups.
Participants were recruited from the outpatient clinic of a women’s health hospital in Seoul, Korea.
Pregnant women (n = 136) completed a survey questionnaire that included questions on depressive
symptoms, anxiety, and pregnancy stress; additionally, their saliva was tested for cortisol hormone
levels three times during their pregnancies. The group-based trajectory modeling approach was used
to identify latent trajectory groups. Ordinal logistic regressions were used to explore the association of
latent trajectory groups with sociodemographic factors and pregnancy stress. Three trajectory groups
of depressive symptoms were identified: low-stable (70%), moderate-stable (25%), and increased (5%).
Four trajectory groups of anxiety were identified: very low-stable (10%), low-stable (67%), moderate-
stable (18%), and high-stable (5%). The only factor associated with both the depressive symptoms
and anxiety trajectory groups was pregnancy stress (p < 0.001). Most participants showed stable
emotional status; however, some participants experienced higher levels of depressive symptoms and
anxiety related to higher pregnancy stress. These pregnant women may need additional care from
healthcare providers to promote their wellbeing during pregnancy.
Keywords: depression; anxiety; cortisol; pregnancy; trajectory analysis; Korea
1. Introduction
Mental health problems such as depression and anxiety are prevalent among pregnant
women, with rates as high as 30% [1–3]. The mental health of pregnant women affects
the health outcomes of both the pregnant women and their infants [4]. Infants born
to mothers who have experienced severe perinatal stress are reported to have altered
behavioral responses to stress. Changes in the antenatal stress-related biology of pregnant
women may be linked to adverse behavioral responses toward their infants [5]. In addition,
depression during pregnancy is often associated with adverse birth outcomes, including
preterm birth, low infant birth weight, and fetal growth restriction [2,6]. Pregnancy is a
time of increased vulnerability to the development of depression. Prevalence of depression
has been estimated at 11.9% among women during the perinatal period, and there is a
significantly higher prevalence in low- to middle-income countries compared to high-
income countries [7]. In Korea, between 20% and 40% of prenatal women have been
reported to have depression, as measured by varying scales [8].
Anxiety is another prevalent problem faced by pregnant women [1,9]. As their due
dates approach, pregnant women are likely to express anxiety and fear regarding the labor
and delivery process [10]. However, multiparous women who have experienced successful
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labor and delivery may have lower anxiety levels than primipara women [11]. Similarly,
certain subgroups of pregnant women may be more vulnerable to anxiety. A strong relation-
ship between anxiety and depression has been established among pregnant women [12].
Three out of every four anxious women are reported to suffer from comorbid depressive
symptoms. In addition, several studies have reported that both anxiety and depressive
symptoms follow a U-shaped curve, with the highest levels of these symptoms occurring
during the first and third trimesters of pregnancy [9,13]. Given the high correlation of
anxiety and depression, it is essential to identify the trajectories of anxiety and depressive
symptoms simultaneously during pregnancy. This type of approach would help to explore
the risk for negative mental health and to provide care for pregnant women during the
appropriate time window. Various factors influencing prenatal anxiety and depression
in women have been investigated; however, inconsistent reports are available regarding
stress, sleep quality, and daily physical activity. Mental health problems before pregnancy,
on the other hand, have been identified as strong predictors of perinatal and postnatal
mental health problems [14–17]. Yet, modifiable influencing factors need to be identified to
prevent the negative consequences of untreated prenatal anxiety and depression on both
mothers and infants [2,18].
In humans, cortisol helps the body cope with stressful situations, but prolonged
exposure to elevated levels of stress causes severe fatigue, anxiety, and depression [4].
As a biomarker of stress, cortisol measurements have been widely utilized in clinics and
research [19]. Cortisol levels in the blood are closely correlated with stress levels in healthy
populations and pregnant women [5,20]. Offering a non-invasive measure, cortisol levels
in saliva are also related to anxiety and depression in pregnant women [19,21,22].
Although there has been extensive research on mental health during pregnancy, it
is still necessary to investigate pregnant women’s patterns of mental health changes as
gestation progresses, as well as the underlying mechanisms; this must be approached
using objective measures, such as biomarkers. Thus, we added a saliva cortisol measure to
the psychobiological variables of women during pregnancy to determine the differences
between the distinct groups identified.
Thus, the primary objective of this study was to investigate the trajectory groups
of depressive symptoms and anxiety of women during pregnancy, and the secondary
objective was to identify the factors associated with those groups.
2. Materials and Methods
2.1. Study Design and Participants
This study used a repeated measures design with a convenience sampling method.
After approval of the study protocol by the Institutional Review Board was obtained,
data collection began. The participants were recruited from the outpatient clinic of a
women’s health hospital located in Seoul, Korea. Pregnant women were eligible for
participation if they were over 20 years of age, their pregnancy (<16 weeks of gestation)
was confirmed by a medical doctor, and they had no known medical illnesses. Exclusion
criteria were twin or triplet pregnancy and diagnosed pregnancy complications such as
gestational hypertension or gestational diabetes mellitus. During the examination, an
obstetric physician briefly introduced the study to each potential participant; a research
assistant provided the detailed research protocol and obtained consent from participants
who showed interest in participation in the study. The survey questionnaire included
questions addressing depression, anxiety, pregnancy-related stress, and sociodemographic
characteristics. Participants were asked to complete the survey questionnaire during the
regular prenatal check-up for each trimester (a total of three times). Of the 149 women
who initially participated, those who reported an abortion (n = 3), transferred to another
hospital (n = 6), or provided incomplete surveys (n = 4) were excluded. Therefore, the final
dataset included 136 surveys that were suitable for statistical analysis.
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2.2. Measures
Before data collection began, trained research assistants provided a detailed research
protocol to potential participants and obtained their informed consent. Participants were
asked to complete the questionnaire and provide their saliva in a clean tube to a research
assistant. The tube with saliva was immediately stored in an icebox and delivered to
the lab at the college of nursing where the analysis was performed. For the second- and
third-trimester data collections, appointments with the women’s obstetric physicians were
recorded, and the same data collection method was used.
2.2.1. Depressive Symptoms
Depressive symptoms were measured using the Korean version of the Center for
Epidemiologic Studies Depression scale (CES-D), whose validity and reliability have been
confirmed within the Korean population. The scale assesses depressive symptoms over the
past week and consists of 20 items scored on a 4-point Likert scale (ranging from 0 to 3).
Total scores range from 0 to 60, with higher scores indicating more depressive symptoms.
Scores above 16 are known to indicate severe depressive symptoms [23]. Cronbach’s α was
0.86 in the present study.
2.2.2. Anxiety
Anxiety was measured using the Korean version of Spielberg’s State-Trait Anxiety
Inventory (STAI-S), which includes 20 items scored on a 4-point Likert scale. Total scores
range from 20 to 80, with higher scores indicating a higher state of anxiety. The optimum
cut-off for the STAI-S during pregnancy is 40 (anxious vs. non-anxious women) [24].
Cronbach’s α of the STAI-S in the present study was 0.92.
2.2.3. Pregnancy Stress
Pregnancy stress was measured using the pregnancy-related stress scale for pregnant
Korean women, developed by Ahn [25] and revised and validated by Lee and Seo [26].
This scale includes 20 items scored on a 5-point Likert scale. Total scores range from 20 to
100, with higher scores indicating greater stress related to pregnancy. Cronbach’s α was
0.89 in the revised study [26] and 0.88 in the present study.
2.2.4. Cortisol Level
In addition to the psychobiological variables, we included the saliva cortisol levels
of the women during early pregnancy to determine the differences between the distinct
groups identified. Given the diurnal characteristics of human cortisol levels and that
the quality of cortisol samples is affected by sampling time, morning is considered the
most common time of day for cortisol collection [21,27]. Therefore, we collected the
saliva in the morning, between 10:00 a.m. and 12:00 p.m., at the outpatient clinic. Before
participants provided saliva samples, they washed their mouths with clean water. The
saliva samples were transported on ice bags and stored at −20 ◦C in the nursing college’s
lab until the analysis was conducted. Salivary cortisol levels were measured using enzyme-
linked immunosorbent assay kits supplied commercially for single measurements; the
supplied standards were assayed in duplicates (R&D Systems, Minneapolis, MN, USA).
The intra- and inter-assay coefficients of variation for salivary cortisol were 6.9% ± 1.9%
and 9.9% ± 0.8%, respectively, which are both within recommended ranges [28].
Cortisol levels generally show skewed distributions within healthy populations. As
changes in cortisol levels related to stress are known to be non-linear, it is appropriate to
compare pregnant women with high levels of cortisol to those with low levels, rather than
using cortisol levels as continuous variables. Thus, in the data analysis, comparison was
made between one group containing three-quarters of the total cortisol level distribution
and another group containing the remaining quarter. When a cortisol level was within the
lower three quantiles, it was assigned 0; when it was within the highest quantile, it was
assigned 1.
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2.2.5. Demographic Information
Information regarding each participant’s age, height, weight, education level, cur-
rent employment status, annual household income (very low, low, middle, and high),
planned pregnancy, and gestational age were obtained. Age was categorized as <35 or
≥35 years. Each participant’s body mass index (BMI) was computed and categorized as
underweight (<18.5 kg/m2), healthy weight (18–23 kg/m2), overweight (23–25 kg/m2), or
obese (≥25 kg/m2) based on the Asian criteria.
2.3. Statistical Analysis
Statistical analysis was performed using IBM SPSS 25 (IBM Corp, Chicago, IL, USA)
and Stata 16 (Stata Corp LLC, College Station, TX, USA). Descriptive statistics were used to
analyze the mean, standard deviation, and frequency of characteristics.
The group-based trajectory modeling approach was used to identify the trajectory
groups of depressive symptoms based on the total CES-D scores and anxiety based on the
STAI-S scores from early to late pregnancy [29]. A series of trajectory model specifications
were systematically tested by determining whether shapes of depressive symptom and
anxiety trajectories were linear, quadratic, or cubic according to the Bayesian information
criterion (BIC). The number of trajectory groups in the model was increased by 1 and
repeated until the best-fit model was found. Once the best-fit model was identified,
a posteriori analysis was performed; the demographic and individual variables were
compared between the trajectory groups with the Kruskal-Wallis test and Fisher’s exact
test. This was performed because the data were unequally distributed among the cells of
the contingency table.
The ordinal logistic regression model was used to identify factors associated with
depressive symptoms and anxiety in pregnant women. We checked the parallel regression
assumption to ensure the coefficients were in the same direction for each category [30].
Although the ordinal logistic regression on anxiety trajectory groups violated the parallel
assumption, gologit2 with the autofit command confirmed the parallel assumption; there
was no difference in the estimated coefficient values. Finally, the ordinal logistic regressions
were conducted with the simultaneous entry of sociodemographic covariates. Adjusted
odds ratios (ORs) and 95% confidence intervals (CIs) are presented to reflect associations
of strength and significance.
3. Results
3.1. Characteristics of Participants
The characteristics of participants by trimester are summarized in Table 1. Over
30% of the participants’ ages were over 35 years, and most (90%) had degrees beyond the
college level. More than half of the participants (55%) reported a planned pregnancy, and
about half of the participants reported middle-class household incomes. Two-thirds of the
participants were employed during pregnancy. About three-fifths of the participants (59%)
reported a healthy pre-pregnancy BMI. Almost none of the participants consumed alcohol
or smoked cigarettes during their pregnancies (alcohol, ≤10%; smoke, ≤1%). Mean cortisol
levels increased as the trimesters progressed. However, pregnancy stress increased until
the second trimester and stabilized thereafter.
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Table 1. Characteristics of participants (n = 136).
Variable n (%) Mean (SD) Min.–Max.
Age (years) <35 93 (68.4) 25–43≥35 43 (31.6)
Education
≤High school 13 (9.6)
College 98 (72.1)
Graduate 25 (18.4)
Employment No 45 (36.3)
Yes 79 (63.7)
Household Income




Planned Pregnancy No 61 (45.2)
Yes 74 (54.8)
Pre-Pregnancy Smoking No 122 (99.2)
Yes 1 (0.8)
Pre-Pregnancy Drinking No 111 (90.2)
Yes 12 (9.8)








Trimester 1 50.71 (10.7) 28–79
Trimester 2 68.48 (9.0) 48–87
Trimester 3 69.02 (9.5) 44–90
Cortisol Levels
Trimester 1 4.44 (4.2) 0.1–25.6
Trimester 2 6.23 (6.3) 0.6–49.4
Trimester 3 7.57 (6.6) 0.3–37.6
BMI = body mass index.
3.2. Correlation between Depressive Symptoms, Anxiety, and Pregnancy Stress in Each Trimester
Associations between depressive symptoms, anxiety, and pregnancy-related stress of
pregnant women are statistically significant in each trimester. All p-values of correlation
are smaller than 0.01, as illustrated in Table 2. In all trimesters, depressive symptoms and
stress were highly correlated, and anxiety and stress were also significantly correlated.









1 Anxiety 0.667 **
Stress 0.485 ** 0.480 **
2 Anxiety 0.750 **
Stress 0.479 ** 0.461 **
3 Anxiety 0.707 **
Stress 0.516 ** 0.606 **
** p < 0.01.
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3.3. Description of Trajectory Group Patterns
A series of model specifications were systematically tested by changing the order of
group numbers and trajectory polynomials (linear, quadratic, and cubic) to choose the
best-fit model using the minimum BIC [29]. Since we conducted measurements three times
during the pregnancies, a curve wave was not appropriate.
Based on the longitudinal patterns of depressive symptoms and the most optimized
for fit with the minimum BIC and quadratic trajectory polynomial, three latent trajectory
groups were identified (Figure 1). These groups were descriptively labeled according to
their patterns of depressive symptoms: (1) low-stable, (2) moderate-stable, and (3) increased.
In this model, the “low-stable” group, which is the largest trajectory group, includes
pregnant women who consistently showed low-stable depressive symptoms and accounts
for 70% of the participants (n = 96). The second largest group (25%), the “moderate-
stable” trajectory group, includes women who showed suboptimal depressive symptoms
that remained consistent. The last trajectory group, “increased” (5%), includes women
whose scores were higher than 16 and whose scores increased in the second trimester and
remained the same during the last trimester.
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Figure 1. Trajectory groups for depression symptoms of pregnant women (n = 136).
Based on the longitudinal patterns of anxiety and the most optimized for fit with
the minimum BIC and linear trajectory polynomial, four latent trajectory groups were
identified (Figure 2). These were descriptively labeled according to their patterns of
anxiety: (1) very low-stable, (2) low-stable (3) moderate-stable, and (4) high-stable. The first
trajectory group, “very low-stable” (10%), is composed of women whose anxiety scores
were the lowest of the participants and relatively stable throughout pregnancy. The largest
trajectory group (67%) was the “low-stable” group, and these anxiety scores were constant
at a higher level than those of the “very low-stable” group. The third trajectory group,
“moderate-stable,” includes women who had moderate-to-high anxiety scores throughout
pregnancy; approximately ne-fifth of t e participants (18%) were in this group. The last
and smallest trajectory group, “high-stable,” includes women who had the highest anxiety
scores throughout pregnancy.
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Low 30 (35.3) 11 (39.3) 4 (66.7) 6 (50.0) 30 (37.0) 6 (30.0) 3 (50.0)
Middle 39 (45.9) 12 (42.9) 2 (33.3) 6 (50.0) 36 (44.4) 9 (45.0) 2 (33.3)
High 12 (14.1) 4 (14.3) 0 (0) 0 (0) 11 (13.6) 4 (20.0) 1 (16.7)
Planned
pregnancy
No 39 (41.1) 17 (50.0) 5 (83.3) 0.110 6 (42.9) 43 (47.3) 9 (37.5) 3 (50.0) 0.844
Yes 56 (58.9) 17 (50.0) 1 (16.7) 8 (57.1) 48 (52.7) 15 (62.5) 3 (50.0)
Regular exercise No 71 (82.6) 25 (86.2) 4 (66.7) 0.420 12 (100) 66 (80.5) 18 (85.7) 4 (66.7) 0.241
Yes 15 (17.4) 4 (13.8) 2 (33.3) 0 (0) 16 (19.5) 3 (14.3) 2 (33.3)
Pre-pregnancy
BMI
<18.5 18 (18.9) 6 (17.6) 1 (16.7) 0.847 3 (21.4) 15 (16.5) 2 (3 . ) 0.798
18.5–23 58 (61.1) 18 (52.9) 4 (66.7) 9 (64.3) 53 (58.2) 16 (66.7) 2 (33.3)
23–25 10 (10.5) 6 (17.6) 0 (0) 1 (7.1) 13 (14.3) 1 (4.2) 1 (16.7)
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Compared to the low-stable depressive symptoms group, the moderate and increased
groups showed significantly higher pregnancy stress (p < 0.001 and p = 0.038, respectively).
The very low-stable anxiety group showed significantly higher pregnancy stress than the
moderate-stable anxiety group (p = 0.029). No other characteristics were found to differ
among the trajectory groups for depressive symptoms and anxiety.
3.3.2. Factors Associated with Trajectory Groups of Depressive Symptoms and Anxiety
Table 4 presents the factors associated with the trajectory groups of depressive symp-
toms and anxiety. Pregnancy stress significantly differed among the trajectory groups of
depressive symptoms (p < 0.01). For a one-unit increase in pregnancy stress, the odds of a
higher category group are 1.13 times greater in depressive symptoms (for example, the low-
stable group [group 1] versus the moderate-stable group [group 2]) when other variables in
the model are held constant. The same amount, which is 1.13 times greater for depressive
symptoms, can be also applied between the moderate-stable and increased groups.
Table 4. Factors associated with predictors of the latent trajectory groups for depressive symptoms and anxiety.
Variables Categories
Depressive Symptoms Trajectory
Groups Anxiety Trajectory Groups
OR p 95% CI OR p 95% CI
Age <35 1.179 0.755 0.42–3.32 0.603 0.273 0.24–1.49≥35
Education
≤High school 1.192 0.722 0.45–3.14 1.079 0.855 0.48–2.45
College
Graduate
Employment No 0.975 0.939 0.51–1.87 0.751 0.362 0.41–1.39
Yes
Household income








No 1.303 0.674 0.38–4.47 0.646 0.405 0.23–1.81
Yes
Pre-Pregnancy BMI




Pregnancy stress 1.133 <0.001 1.08–1.19 1.088 <0.001 1.04–1.14
Cortisol level
≤75% 0.590 0.375 0.18–1.89 0.566 0.241 0.22–1.47
>75%
OR = odds ration; CI = confidence interval; BMI = body mass index.
In terms of anxiety, pregnancy stress significantly differed among the trajectory groups
of anxiety (p < 0.01). For a one-unit increase in pregnancy stress, the odds of a higher
category group are 1.09 times greater in anxiety (for example, the very-low stable group
[group 1] versus the low stable group [group 2]) when the other variables in the model
remain constant. The same increase, 1.09 times, can be applied between the low-stable
group (group 2) and the moderate-stable group (group 3).
4. Discussion
This longitudinal study identified distinct trajectory groups of depressive symptoms
and anxiety levels in Korean women during pregnancy and explored potentially influencing
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factors. Three latent trajectory groups of depressive symptoms and four latent trajectory
groups of anxiety were identified. The three latent trajectory groups were ‘low-stable’
(70%), ‘moderate-stable’ (25%), and ‘increased’ (5%). The four anxiety trajectory groups
were very low-stable (10%), low-stable (67%), moderate-stable (18%), and high-stable (5%).
Depression and anxiety are common complaints among pregnant women and are
sometimes severe for certain women during the prenatal period [10,31]. The trajectory
groups based on patterns of depressive symptoms identified three heterogeneous groups:
low, moderate, and increased depressive symptom levels. This finding is consistent with
previous studies demonstrating the “low” trajectory represented by a stable pattern of
low symptom levels over time, which usually accounts for the largest trajectory group
(70%) [32]. The “increased” trajectory group also aligned with previous studies’ results;
this group had increased depressive symptoms in the second trimester that persisted
over time, forming the smallest trajectory group (≤10%) [32]. Despite being the smallest
group in this study, this group of women should be investigated as an at-risk group for
mental health problems because all women in the “increased” trajectory group scored over
16 on the CES-D, reflecting high levels of depressive symptoms. Tailored and continuous
intervention for this group is required during early pregnancy.
Considering the four anxiety trajectory groups, our results are consistent with previous
studies [1,33] showing that the trajectory patterns of anxiety were stable. Anxiety during
pregnancy seems to remain consistent without abrupt changes, although state anxiety
(rather than trait anxiety) was measured in this study. Being pregnant involves daily life
that differs from the pre-pregnancy period, requiring caution against excessive weight
gain and the need to maintain a good diet and sleep behavior. This finding also implies
that an initial assessment of anxiety during early pregnancy can be used predictively, and
high anxiety levels need management accordingly, due to their persistence throughout
pregnancy [1].
Stress related to pregnancy is differentiated among the trajectory groups of both
depressive symptoms and anxiety, according to the results from both the univariate and
ordinal logistic regression analyses in this study. Stress is known to significantly and
negatively impact the mental health of pregnant women. Perceived stress was associated
with high levels of anxiety early in pregnancy [34]. Pregnancy-related stress can be related
to negative emotions and cognitions about pregnancy and birth. Although a longitudinal
design was used, the causal relationship between stress and depressive symptoms and
anxiety cannot be identified.
Several studies have reported significant associations between antenatal depres-
sion and anxiety and sociodemographic characteristics, including age, education, and
income [10,32,35], but no significant characteristics were noted in the present study. The
majority of participants in this study were mature and older, ranging from 25 to 42 years,
and more than 90% were at least college graduates. Almost none of the participants smoked
cigarettes or consumed alcohol during their current pregnancies. These characteristics
demonstrate that they were homogeneous and higher in socioeconomic status than the
general population, which may affect mental health status. Past psychiatric history, post-
traumatic stress disorder, and partner (or family) relationships were found to adversely
affect the mental health of pregnant women [10].
This study is unique as it included cortisol levels to identify factors associated with
mental health in pregnant women. Similar to previous studies, the average cortisol levels
were increased during pregnancy [36]. However, the cortisol levels were not found to
be a significant factor in the present study. This may be due to the fact that cortisol was
measured using saliva that was only collected once, thus potentially not offering an accurate
reflection of the participants’ overall stress levels. In fact, a few previous studies reported a
lack of concordance in subjective (questionnaires) and objective (salivary cortisol) stress
measures [37,38].
Considering the underdiagnosis of depression and anxiety during pregnancy, the
results of this study are extremely important. Stress related to pregnancy itself during this
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period, as the only factor affecting mental health, should be assessed due to its interrelations
with other aspects of mental health. The major finding of this study indicates that a small
number of women showed increased depressive symptoms as their pregnancies progressed;
therefore, greater attention and care are needed to prevent adverse obstetric outcomes
within this group of women. Unlike depressive symptoms, anxiety assessed during early
pregnancy did not change abruptly, so early and timely screening by healthcare providers
could reduce anxiety symptoms in pregnant women. Rather than dismissing the efforts to
reduce symptoms of depression and anxiety as a matter for individual patients, healthcare
providers should assess for and provide information about stress, depression, and anxiety
in places such as obstetrics and gynecology clinics, outpatient services, and prenatal classes.
The present study is significant as it is one of the few longitudinal studies in Korea that
repeatedly measured psychological and biological changes during pregnancy. However,
only the pregnancy period was included, and the study did not examine other influential
factors such as past psychiatric history, postpartum period, birth outcomes, and partner (or
family, spouse) factors (such as relationship, support, and psychological adjustment). In
addition, the sample size is not large, which prevents the results from being statistically
significant and limits the evidence of the specific symptoms and the configuration of
the symptoms that constitute the maternal depressive symptoms/anxiety heterogeneity.
Despite the longitudinal aspect of the models, a possible causal relationship should be
considered with caution. Therefore, to find the most predictive characteristics for different
depressive symptoms and anxiety trajectories, studies with larger samples and more
diverse settings are suggested.
5. Conclusions
The present study found that depressive symptoms and anxiety in pregnant women
showed several distinct trajectory groups that are associated with stress related to preg-
nancy. A small number of women experienced high levels of depressive symptoms through-
out pregnancy, and anxiety assessed in early pregnancy persisted without abrupt changes.
Perceived stress should be assessed and managed in pregnant women due to its inter-
relation with other mental health problems. Thus, an early screening of mental health
is important in assisting healthcare providers in detecting women who are at a risk for
adverse pregnancy outcomes. Additional care should be provided to identified risk groups
of pregnant women, and the underlying mechanisms of those high-risk pregnant women
needs to be investigated. The results of this study provide useful information for the
development of interventions targeting pregnant women who may need assessment and
care from healthcare providers. Further studies are needed to investigate patterns within
larger and heterogeneous groups of pregnant women, including the prenatal and postna-
tal periods.
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